HSA — authorised 20 February 1945
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
🇸🇬 Dextrotubocurarine Chloride in Singapore
HSA authorised Dextrotubocurarine Chloride on 20 February 1945
Marketing authorisation
Dextrotubocurarine Chloride in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Singapore
Frequently asked questions
Is Dextrotubocurarine Chloride approved in Singapore?
Yes. HSA authorised it on 20 February 1945.
Who is the marketing authorisation holder for Dextrotubocurarine Chloride in Singapore?
BRISTOL MYERS SQUIBB holds the Singaporean marketing authorisation.